For appointments, please call:
(303) 823-4882TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment Resistant Depression and for Major Depression with suicidality. FDA approval will result in insurance coverage for this form of ketamine, for this purpose, which will make it affordable for millions of suffering patients. Although it is...
We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…
Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…
A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…
Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…
Many of our ketamine therapy patients tell us that the COVID-19 pandemic is causing a dramatic increase in their…